Genome Editing Industry

  • The genome editing market is presently witnessing significant growth due to increase in R&D expenditure, rise in government funding for genomic research, technological advancements, and growth in production of genetically modified crops. Genomic editing refers to the strategies and techniques implemented for the modification of target genetic information of any living organism.

  • Genome editing market report provides all the major factors, such as drivers, restraints, opportunities, trends that are impacting the growth of the genome editing in the forecasted period. The market is expected to reach US$ 10,691.0 Mn in 2025 . Research delivers insight into the Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., Thermo Fisher Scientific Inc.